Journal: Endocrinology

Article Title: GLP-1 Receptor Expression Within the Human Heart

doi: 10.1210/en.2018-00004

Figure Lengend Snippet: Antibodies Used

Article Snippet: Immunoprecipitations were performed using 1 mg/mL of cell or tissue protein extract and 2 μg/mL of rabbit polyclonal anti-human GLP-1R antibody [Novus 19400002; Research Resource Identifier (RRID) AB_10004637 ; Bio-Techne, Oakville, ON, Canada] overnight at 4°C.

Techniques: Sequencing

Journal: Endocrinology

Article Title: GLP-1 Receptor Expression Within the Human Heart

doi: 10.1210/en.2018-00004

Figure Lengend Snippet: GLP1R mRNA transcript levels in the human heart are comparable to those in human pancreas and islets. (A) GLP1R mRNA levels were measured via qPCR analysis in multiple human tissues and in transfected BHK cells that express low levels of the human GLP-1R. For data represented without standard error bars, each single RNA sample was analyzed in duplicate; for isolates depicted with error bars, peripheral blood lymphocyte samples were analyzed in duplicate from two different sources, and at least three different samples were analyzed in duplicate by qPCR for RNAs from islet, bone marrow, left atria (LA), right atria (RA), left ventricle (LV), and right ventricle (RV). (B) qPCR analysis of GLP1R and tissue- or cell-type–specific gene expression in the indicated samples as confirmation of RNA/cDNA integrity. For (A) and (B), data are expressed as cycle threshold (Ct) values because none of the housekeeping genes examined (ACTB, GPI, PSMB4, CHMP2A, and EMC7) exhibited consistent expression levels in all tissues examined. Values are mean ± standard error (where appropriate); n = 1 to 3 samples per tissue. LA samples are from patients P01371, P01430, and P01504. RA samples are from patients P01262, P01371, and P01377. LV samples are from patients P01262, P01430, and P01371. RV samples are from patients P01262, P01371, and P01504 (see Supplemental Table 1 and Figure 4). Islet samples are from donors R177, R199, and R200 (see Supplemental Table 3). CA EC, coronary artery endothelial cells; CA SMC, coronary artery smooth muscle cells; PBL, peripheral blood lymphocytes; Card FB, cardiac fibroblasts.

Article Snippet: Immunoprecipitations were performed using 1 mg/mL of cell or tissue protein extract and 2 μg/mL of rabbit polyclonal anti-human GLP-1R antibody [Novus 19400002; Research Resource Identifier (RRID) AB_10004637 ; Bio-Techne, Oakville, ON, Canada] overnight at 4°C.

Techniques: Transfection, Expressing

Journal: Endocrinology

Article Title: GLP-1 Receptor Expression Within the Human Heart

doi: 10.1210/en.2018-00004

Figure Lengend Snippet: (A) Western blot analysis of whole cell or human islet tissue extracts using GLP-1R antibodies against the human GLP-1R, Mab 3F52, or polyclonal Novus. Molecular mass standards (kDa) are indicated in the center. Blots on the left contain whole cell extracts from BHK pcDNA3 (lane 1), BHK clone #12A (lane 2), BHK clone #13 (lane 3), BHK clone #27 (lane 4), and CFPAC-1 cells (lane 5). Blots on the right contain whole cell extracts from BHK clone #12A (lane 1) and whole tissue extracts from human islets #167 (lane 2), #177 (lane 3), #186 (lane 4), and 199 (lane 5). The blot on the far right was immunoblotted with Akt and Erk1/2 antibodies as loading controls. (B) Western blot analysis of whole cell or human cardiac tissue extracts analyzed using the indicated GLP-1R antibody. Molecular mass standards (kDa) are indicated in the center. Immunoblotting with Akt and Erk1/2 antibodies (bottom panels) was used as loading controls. In (A) and (B), the brackets indicate predicted migration positions of immunoreactive GLP-1R protein.

Article Snippet: Immunoprecipitations were performed using 1 mg/mL of cell or tissue protein extract and 2 μg/mL of rabbit polyclonal anti-human GLP-1R antibody [Novus 19400002; Research Resource Identifier (RRID) AB_10004637 ; Bio-Techne, Oakville, ON, Canada] overnight at 4°C.

Techniques: Western Blot, Migration

Journal: Endocrinology

Article Title: GLP-1 Receptor Expression Within the Human Heart

doi: 10.1210/en.2018-00004

Figure Lengend Snippet: (A) Whole cell/tissue extracts after immunoprecipitation (IP) and Western blotting with the indicated GLP-1R antibodies. Lanes 1 and 2 are whole cell extracts, and lanes 3 through 8 correspond to immunoprecipitated samples. Lane 1, BHK pcDNA3; lane 2, BHK clone #12A; lane 3, BHK clone #12A; lane 4, BHK clone #13; lane 5, human islet #167; lane 6, human islet #177; lane 7, human islet #186; and lane 8, human islet #199. Molecular mass standards (kDa) are indicated on the left. (B) Whole tissue extracts from human heart chamber samples after IP and Western blotting with the indicated GLP-1R antibodies. Molecular mass standards (kDa) are indicated on the far left and right of the blots. In (A) and (B), the brackets indicate predicted migration positions of immunoreactive GLP-1R protein.

Article Snippet: Immunoprecipitations were performed using 1 mg/mL of cell or tissue protein extract and 2 μg/mL of rabbit polyclonal anti-human GLP-1R antibody [Novus 19400002; Research Resource Identifier (RRID) AB_10004637 ; Bio-Techne, Oakville, ON, Canada] overnight at 4°C.

Techniques: Immunoprecipitation, Western Blot, Migration

Journal: Endocrinology

Article Title: GLP-1 Receptor Expression Within the Human Heart

doi: 10.1210/en.2018-00004

Figure Lengend Snippet: GLP-1R immunohistochemistry with Mab 3F52 does not detect GLP-1R–immunoreactive cells in human ventricular tissue. Immunostaining of hyperplastic human Brunner glands with isotype control antibody (A) and GLP-1R Mab 3F52 (B). The Novus 19400002 antibody did not reliably detect GLP-1R–immunopositive cells in sections containing human Brunner glands (data not shown). Immunostaining of human pancreas with isotype control antibody (C) and GLP-1R Mab 3F52 (D). (E–P) GLP-1R Mab 3F52 immunostaining of human cardiac tissues from individual subjects [(E) 193856; (F) 61704; (G) 70150; (H) 70847; (I) 81858; (J) 164011; (K) 116603; (L) 166469; (M) 179268; (N) 171263; (O) 182651; (P), 52411; see Supplemental Table 2].

Article Snippet: Immunoprecipitations were performed using 1 mg/mL of cell or tissue protein extract and 2 μg/mL of rabbit polyclonal anti-human GLP-1R antibody [Novus 19400002; Research Resource Identifier (RRID) AB_10004637 ; Bio-Techne, Oakville, ON, Canada] overnight at 4°C.

Techniques: Immunohistochemistry, Immunostaining

Journal: The Journal of nutrition

Article Title: Mango Supplementation Modulates Gut Microbial Dysbiosis and Short-Chain Fatty Acid Production Independent of Body Weight Reduction in C57BL/6 Mice Fed a High-Fat Diet.

doi: 10.3945/jn.115.226688

Figure Lengend Snippet: FIGURE 2 Protein expression of pancreatic in- cretin receptors in C57BL/6 mice fed a control diet or an HF diet supplemented with 0%, 1%, or 10% mango for 12 wk. GLP1R (A) and GIPR (B) protein expression were determined via immunoblot anal- ysis (normalized to b-actin) in the pancreas of mice after 12 wk of dietary treatment. Data are means 6 SEMs (n = 5 mice/group). Labeled means without a common letter differ, P # 0.05. C, control; GIPR, gastric inhibitory peptide receptor; GLP1R, glucagon- like peptide 1 receptor; HF, high fat; HF+1%M, high fat + 1% mango; HF+10%M, high fat + 1% mango.

Article Snippet: Total protein (20 mg) was electrophoretically separated by use of SDS-PAGE and transferred to PVDF membranes (ThermoScientific), and membranes were blocked with 5% nonfat dried milk (Nestle) followed by overnight incubation at 4 C with the following rabbit polyclonal antibodies: GLP1R and GIPR (Santa Cruz Biotechnology) and b-actin (Cell Signaling Technology).

Techniques: Expressing, Control, Western Blot, Labeling